RK

Ramesh Khimabhai Karangia

Active Director Director DIN 09002357
DIN 09002357 First appointment Dec 2020 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramesh Khimabhai Karangia

Data last updated:

Ramesh Khimabhai Karangia is a Director at Best Heal Hospital Private Limited (since 2020). The company operates in Healthcare.

DIN 09002357
Primary Designation Director
Industry Healthcare
First Appointment 18 Dec 2020
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Best Heal Hospital Private Limited U85320GJ2020PTC118961
Director18 Dec 20202020Active

Board colleagues of Ramesh Khimabhai Karangia

NameDINCompanyDesignation
Samirsanjav Makwana09002356Best Heal Hospital Private LimitedDirector

Directorship timeline

Open interactive timeline →
Best Heal Hospital Private Limited
Premium access

Shareholding and investment profile for Ramesh Khimabhai Karangia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramesh Khimabhai Karangia

Ramesh Khimabhai Karangia currently holds 1 directorship: Best Heal Hospital Private Limited (Director, since 18 Dec 2020).

Ramesh Khimabhai Karangia was first appointed on 18 Dec 2020 as Director at Best Heal Hospital Private Limited.

The current boards of Ramesh Khimabhai Karangia's companies include Samirsanjav Makwana (Best Heal Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available